PetCaseFinder

Peer-reviewed veterinary case report

Scottish Fold cat with painful bone disease treated with radiation

By Selting, Kim A et al.·Published in Journal of the American Animal Hospital Association·2019·From the Department of Veterinary Medicine and Surgery·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Osteochondrodysplasia in a Scottish Fold Cat Treated with Radiation Therapy and Samarium-153-1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetramethylene-Phosphonic Acid.

Species:
cat
Osteoarthritis in catsStomach & digestionCats

Plain-English summary

An 8-year-old male neutered Scottish Fold cat was brought in because of a painful mass on his hind paw, which made it hard for him to move. Due to the breed's genetic issues causing bone problems, the owner chose not to amputate the mass. Instead, the vet used radiation therapy to help relieve the cat's pain, which worked for about 14 months. After that, a special treatment called samarium-153 was given, which quickly improved the cat's mobility. Unfortunately, he later developed heart-related issues that led to his passing.

People also search for: Scottish Fold cat mass on paw · cat pain relief treatments · samarium-153 for cats · cat mobility improvement · Scottish Fold osteochondrodysplasia treatment

Abstract

Osteochondrodysplasia is a painful, progressive clinical syndrome unique to Scottish fold cats because of a heritable missense mutation in the TRPV4 gene. An 8 yr old male neutered Scottish fold cat was presented for a mass on his hind paw. The mass caused decreased mobility in the metatarsal region and digits and resulted in significant discomfort. Because of extensive skeletal abnormalities attributed to breed-related osteochondrodysplasia, the owner was reluctant to pursue amputation. Radiation therapy was pursued for palliation of pain. After coarsely fractionated external beam radiotherapy resulted in stabilization of the mass with eventual progression after 14 mo, samarium-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid was administered systemically, and the cat showed immediate, whole-body improvement in mobility. Concurrent intestinal and respiratory disease was evaluated and managed. Samarium-153-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetramethylene phosphonic acid administration was repeated approximately every 6 mo for three treatments until the cat succumbed to thromboembolic disease attributed to previously diagnosed cardiac disease. Radiation therapy administered using either external beam or bone-seeking radioisotopes can be effective at palliating clinical signs associated with the skeletal abnormalities that accompany this disease.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/30870611/